Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LB1148 for Pulmonary Dysfunction in COVID-19 Pneumonia
NCT04390217Phase 2Withdrawn
- Sponsor
- Leading BioSciences, Inc.
- Start
- Oct 2021
- Primary completion
- Dec 2021
- Modality
- Small Molecules, Drug Delivery Systems
01
Overview
A Phase 2 trial of LB1148 in COVID-19 pneumonia, sponsored by Leading BioSciences, Inc.. Planned start Oct 2021; status: withdrawn.
02
Drugs
LB1148
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT04390217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04390217.